BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22651800)

  • 1. New 5-(nitroheteroaryl)-1,3,4-thiadiazols containing acyclic amines at C-2: synthesis and SAR study for their antileishmanial activity.
    Tahghighi A; Emami S; Razmi S; Rezazade Marznaki F; Kabudanian Ardestani S; Dastmalchi S; Kobarfard F; Shafiee A; Foroumadi A
    J Enzyme Inhib Med Chem; 2013 Aug; 28(4):843-52. PubMed ID: 22651800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro anti-leishmanial activity of 1-[5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-yl]- and 1-[5-(5-nitrothiophen-2-yl)-1,3,4-thiadiazol-2-yl]-4-aroylpiperazines.
    Behrouzi-Fardmoghadam M; Poorrajab F; Ardestani SK; Emami S; Shafiee A; Foroumadi A
    Bioorg Med Chem; 2008 Apr; 16(8):4509-15. PubMed ID: 18321711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives.
    Foroumadi A; Emami S; Pournourmohammadi S; Kharazmi A; Shafiee A
    Eur J Med Chem; 2005 Dec; 40(12):1346-50. PubMed ID: 16095763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1,2,3-triazol-4-yl)methyl] moieties.
    Tahghighi A; Razmi S; Mahdavi M; Foroumadi P; Ardestani SK; Emami S; Kobarfard F; Dastmalchi S; Shafiee A; Foroumadi A
    Eur J Med Chem; 2012 Apr; 50():124-8. PubMed ID: 22336386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1,3,4-thiadiazoles with piperazinyl-linked benzamidine substituents.
    Tahghighi A; Marznaki FR; Kobarfard F; Dastmalchi S; Mojarrad JS; Razmi S; Ardestani SK; Emami S; Shafiee A; Foroumadi A
    Eur J Med Chem; 2011 Jun; 46(6):2602-8. PubMed ID: 21501907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antileishmanial activity of 5-(5-nitroaryl)-2-substituted-thio-1,3,4-thiadiazoles.
    Alipour E; Emami S; Yahya-Meymandi A; Nakhjiri M; Johari F; Ardestani SK; Poorrajab F; Hosseini M; Shafiee A; Foroumadi A
    J Enzyme Inhib Med Chem; 2011 Feb; 26(1):123-8. PubMed ID: 20578974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-(Bipiperidin-1-yl)-5-(nitroaryl)-1,3,4-thiadiazoles: Synthesis, evaluation of in vitro leishmanicidal activity, and mechanism of action.
    Mojallal-Tabatabaei Z; Foroumadi P; Toolabi M; Goli F; Moghimi S; Kaboudanian-Ardestani S; Foroumadi A
    Bioorg Med Chem; 2019 Aug; 27(16):3682-3691. PubMed ID: 31300318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro leishmanicidal activity of 2-(5-nitro-2-furyl) and 2-(5-nitro-2-thienyl)-5-substituted-1,3,4-thiadiazoles.
    Foroumadi A; Pournourmohammadi S; Soltani F; Asgharian-Rezaee M; Dabiri S; Kharazmi A; Shafiee A
    Bioorg Med Chem Lett; 2005 Apr; 15(8):1983-5. PubMed ID: 15808452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective leishmanicidal effect of 1,3,4-thiadiazole derivatives and possible mechanism of action against Leishmania species.
    Poorrajab F; Ardestani SK; Foroumadi A; Emami S; Kariminia A; Behrouzi-Fardmoghadam M; Shafiee A
    Exp Parasitol; 2009 Apr; 121(4):323-30. PubMed ID: 19124020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines.
    Marchand P; Bazin MA; Pagniez F; Rivière G; Bodero L; Marhadour S; Nourrisson MR; Picot C; Ruchaud S; Bach S; Baratte B; Sauvain M; Pareja DC; Vaisberg AJ; Le Pape P
    Eur J Med Chem; 2015 Oct; 103():381-95. PubMed ID: 26383125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents.
    Marhadour S; Marchand P; Pagniez F; Bazin MA; Picot C; Lozach O; Ruchaud S; Antoine M; Meijer L; Rachidi N; Le Pape P
    Eur J Med Chem; 2012 Dec; 58():543-56. PubMed ID: 23164660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
    Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J
    Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitroimidazolyl-1,3,4-thiadiazole-based anti-leishmanial agents: synthesis and in vitro biological evaluation.
    Poorrajab F; Ardestani SK; Emami S; Behrouzi-Fardmoghadam M; Shafiee A; Foroumadi A
    Eur J Med Chem; 2009 Apr; 44(4):1758-62. PubMed ID: 18485538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Comparison of In Vitro Leishmanicidal Activity of 5-(Nitroheteroaryl)-1,3,4-Thiadiazols Containing Cyclic Amine of Piperidin-4-ol at C-2 with Acyclic Amine Analogues against Iranian Strain of
    Tahghighi A; Foroumadi A; Kabudanian-Ardestani S; Mahdian SMA
    J Arthropod Borne Dis; 2017 Mar; 11(1):95-104. PubMed ID: 29026856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
    Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, antileishmanial, and antifungal biological evaluation of novel 3,5-disubstituted isoxazole compounds based on 5-nitrofuran scaffolds.
    Trefzger OS; Barbosa NV; Scapolatempo RL; das Neves AR; Ortale MLFS; Carvalho DB; Honorato AM; Fragoso MR; Shuiguemoto CYK; Perdomo RT; Matos MFC; Chang MR; Arruda CCP; Baroni ACM
    Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900241. PubMed ID: 31840866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel antileishmanial chalconoids: synthesis and biological activity of 1- or 3-(6-chloro-2H-chromen-3-yl)propen-1-ones.
    Nazarian Z; Emami S; Heydari S; Ardestani SK; Nakhjiri M; Poorrajab F; Shafiee A; Foroumadi A
    Eur J Med Chem; 2010 Apr; 45(4):1424-9. PubMed ID: 20074836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of N-(1-methyl-1H-indol-3-yl)methyleneamines and 3,3-diaryl-4-(1-methyl-1H-indol-3-yl)azetidin-2-ones as potential antileishmanial agents.
    Singh GS; Al-Kahraman YM; Mpadi D; Yasinzai M
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5704-6. PubMed ID: 22832310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antileishmanial activity of novel pyridinium-hydrazone derivatives.
    Alptuzun V; Cakiroglu G; Limoncu ME; Erac B; Hosgor-Limoncu M; Erciyas E
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):960-7. PubMed ID: 22803671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydropyrido[2,3-d]pyrimidines as a new class of antileishmanial agents.
    Agarwal A; Ramesh ; Ashutosh ; Goyal N; Chauhan PM; Gupta S
    Bioorg Med Chem; 2005 Dec; 13(24):6678-84. PubMed ID: 16126395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.